Investegate |Serinus Energy PLC Announcements | Serinus Energy PLC: Director/PDMR Shareholding
Investegate announcements from Serinus Energy PLC, Director/PDMR Shareholding
Stay updated with breaking news from Statements This. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Serinus Energy PLC, Director/PDMR Shareholding
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England
500 1,000 1,500 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Significant Pent - Up Demand x Following the Great Recession, homeowner investment in... | January 10, 2022
Investegate announcements from Serinus Energy PLC, Director/PDMR Purchase of Shares
- Initiated Phase 2 VIBRANT study of vurolenatide for short bowel syndrome (SBS) in Q2; total stool output (TSO) is primary endpoint following FDA guidance -- Expect Phase 2 data from VIBRANT in Q4 2021